Inventor · Shanghai, CN

Dawei Cui

16Patents
4h-index
22Co-inventors
56Inventor score

Filing activity: Apr 23, 2010 → Jan 20, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9474779B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 26 Active
US9850277B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 17 Active
US11040036B2 Pyruvate kinase activators for use in treating blood disorders Human Necessities 6 Active
US11459327B1 Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof Emerging Cross-Sectional Technologies 4 Active
US11364240B2 Pyruvate kinase activators for use in treating blood disorders Human Necessities 3 Active
US10640534B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 2 Active
US11464775B2 Pyruvate kinase modulators and use thereof Human Necessities 2 Active
US11590132B2 Pyruvate kinase activators for use in treating blood disorders Human Necessities 1 Active
US8569463B2 Method of covalently modifying proteins with organic molecules to prevent aggregation Human Necessities 1 Active
US10717764B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 1 Active
US11957680B2 Pyruvate kinase activators for use in treating blood disorders Human Necessities 0 Active
US11872225B2 Pyruvate kinase modulators and use thereof Human Necessities 0 Active
US10689414B2 Therapeutically active compounds and their methods of use Human Necessities 0 Active
US11667673B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 0 Active
US11021515B2 Therapeutically active compounds and their methods of use Human Necessities 0 Active
US12133853B2 Pyruvate kinase activators for use in treating blood disorders Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.